What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
about
HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settingsLipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.Body Composition and Metabolic Syndrome Components on Lipodystrophy Different Subtypes Associated with HIVAssessment of ultrasound for use in detecting lipoatrophy in HIV-infected patients taking combination antiretroviral therapy.Self-reported body changes and associated factors in persons living with HIV.Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy.The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristicsGenes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapyImpact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy.HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.Management of the metabolic effects of HIV and HIV drugs.People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.A review of the aetiology of dyslipidaemia and hyperlipidaemia in patients with HIV.High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral TherapyApproach to the human immunodeficiency virus-infected patient with lipodystrophyHormonal contraception and HIV-positive women: metabolic concerns and management strategiesFat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort StudyThe forum for collaborative HIV research: a model for an integrated and inclusive approach to clinical research and drug development.Prevalence and factors associated with lipodystrophy in AIDS patients.Experiences of HIV stigma: the role of visible symptoms, HIV centrality and community attachment for people living with HIV.Endocrinological aspects of HIV infection.The phenomenology of body image in men living with HIV.Balancing disfigurement and fear of disease progression: Patient perceptions of HIV body fat redistribution.Contemporary surgical management of HIV-associated facial lipoatrophy.
P2860
Q28088839-0CADC3B8-630E-4228-9699-0CB3A9D3F57AQ31143771-F2B5486B-E83F-4B54-8FD2-EB81B83D9D1AQ33678847-2D6F47DB-4945-4512-BBB5-A21C43F7886CQ33797575-4F25C5A4-C8A6-464F-8D31-C6614B268638Q34367841-BECC9FC4-CAC8-43D9-AFF8-58BD0AB827C8Q34501780-E3C67249-2DDF-45DA-A06E-AEF6E58A8AF4Q35104013-D8038159-B0EF-4F19-93E3-FF349881E5FFQ35206623-E4DA6815-D1AD-4DF7-B7B4-0673B7577042Q35535757-979022E1-E837-4C7A-BE3A-B2ED37ED2A2AQ35637346-41B6F561-8F1F-463E-B047-3B8979063720Q35823452-D22A99BF-D29E-4146-A89D-7ED043470CFDQ35872430-E6D5CFFD-D758-47A5-8B09-747DC7F99F4FQ36007239-C4D4749B-A9BF-4170-AB1C-572E959D6072Q36021411-E99CD4D6-7C22-4D4B-A8B1-D7A1BC444D40Q36249550-66FA7E8D-6AF9-4BD3-9123-DE4D1F5143CDQ36292303-E9D2C0E7-33AE-4D35-AFF3-2C8E73C29F28Q36449095-69286B2A-C69C-48BB-A8A9-9946F001AC1FQ36834945-F8210CB0-3FD1-4019-B648-A65BA842AB91Q37202281-0D68A990-E057-4F50-95F3-BA6556B0478DQ37203062-2387A54C-4577-4B84-BD92-845B5BA5F4C9Q37566190-E528951B-5DC6-4FBB-8DE3-0A4B1079BA99Q42225235-AE5A6F1D-4454-42E9-8607-A0B6048C4922Q45919429-010094B8-2F91-45B9-BCAF-72F5B3D0DF33Q47219853-411AAACC-CCBF-4D96-98BB-2534765B3075Q50715173-76562B38-80C9-4001-80EC-BB2B396A3E3EQ50925529-996ADDB8-D008-4ACA-97C7-5F9B92A7BF95Q51191944-8D16CA04-C19D-4ED6-8C75-F43ED08BBEC3
P2860
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
@ast
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
@en
type
label
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
@ast
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
@en
prefLabel
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
@ast
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
@en
P1476
What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection.
@en
P2093
Carl Grunfeld
Phyllis C Tien
P356
10.1097/00001432-200402000-00005
P577
2004-02-01T00:00:00Z